These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 25150263)
21. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience. Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974 [TBL] [Abstract][Full Text] [Related]
22. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183 [TBL] [Abstract][Full Text] [Related]
23. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
24. Optimizing dosing of antibiotics in critically ill patients. Parker SL; Sime FB; Roberts JA Curr Opin Infect Dis; 2015 Dec; 28(6):497-504. PubMed ID: 26382000 [TBL] [Abstract][Full Text] [Related]
25. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing. Bland CM; Pai MP; Lodise TP Pharmacotherapy; 2018 Dec; 38(12):1229-1238. PubMed ID: 30403305 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing. Onufrak NJ; Forrest A; Gonzalez D Clin Ther; 2016 Sep; 38(9):1930-47. PubMed ID: 27449411 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive Guidance for Antibiotic Dosing in Obese Adults. Meng L; Mui E; Holubar MK; Deresinski SC Pharmacotherapy; 2017 Nov; 37(11):1415-1431. PubMed ID: 28869666 [TBL] [Abstract][Full Text] [Related]
28. Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia. Fish DN; Kiser TH Pharmacotherapy; 2013 Oct; 33(10):1022-34. PubMed ID: 23744833 [TBL] [Abstract][Full Text] [Related]
29. Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients. Roberts JA; Kirkpatrick CM; Lipman J J Antimicrob Chemother; 2011 Feb; 66(2):227-31. PubMed ID: 21118912 [TBL] [Abstract][Full Text] [Related]
30. How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients. Heffernan AJ; Sime FB; Taccone FS; Roberts JA Curr Opin Infect Dis; 2018 Dec; 31(6):555-565. PubMed ID: 30299354 [TBL] [Abstract][Full Text] [Related]
31. A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients. Heffernan AJ; Mohd Sazlly Lim S; Lipman J; Roberts JA Anaesth Crit Care Pain Med; 2021 Dec; 40(6):100970. PubMed ID: 34728411 [TBL] [Abstract][Full Text] [Related]
32. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. Roberts JA; Kirkpatrick CM; Roberts MS; Dalley AJ; Lipman J Int J Antimicrob Agents; 2010 Feb; 35(2):156-63. PubMed ID: 20018492 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic issues for antibiotics in the critically ill patient. Roberts JA; Lipman J Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens. Scaglione F; Paraboni L Int J Antimicrob Agents; 2008 Oct; 32(4):294-301. PubMed ID: 18621508 [TBL] [Abstract][Full Text] [Related]
35. Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures. Carlier M; Noë M; Roberts JA; Stove V; Verstraete AG; Lipman J; De Waele JJ J Antimicrob Chemother; 2014 Oct; 69(10):2797-803. PubMed ID: 24917580 [TBL] [Abstract][Full Text] [Related]
36. What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review. Parker S; Lipman J; Koulenti D; Dimopoulos G; Roberts JA Int J Antimicrob Agents; 2013 Oct; 42(4):289-93. PubMed ID: 23880170 [TBL] [Abstract][Full Text] [Related]
37. Individualized antibiotic therapy in the treatment of severe infections. Annoni F; Grimaldi D; Taccone FS Expert Rev Anti Infect Ther; 2020 Jan; 18(1):27-35. PubMed ID: 31755789 [No Abstract] [Full Text] [Related]
38. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill. Tsai D; Lipman J; Roberts JA Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420 [TBL] [Abstract][Full Text] [Related]
39. Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice? Scaglione F Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S40-2. PubMed ID: 26607342 [TBL] [Abstract][Full Text] [Related]
40. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion. Esteve-Pitarch E; Padullés-Zamora A; Maisterra-Santos K; Colom-Codina H; Cobo-Sacristán S Farm Hosp; 2019 Sep; 43(5):151-157. PubMed ID: 31469627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]